Annual EBIT
$159.07 M
+$124.71 M+362.88%
December 31, 2023
Summary
- As of February 12, 2025, COLL annual earnings before interest & taxes is $159.07 million, with the most recent change of +$124.71 million (+362.88%) on December 31, 2023.
- During the last 3 years, COLL annual EBIT has risen by +$102.61 million (+181.72%).
- COLL annual EBIT is now at all-time high.
Performance
COLL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$33.97 M
-$10.71 M-23.97%
September 30, 2024
Summary
- As of February 12, 2025, COLL quarterly earnings before interest & taxes is $33.97 million, with the most recent change of -$10.71 million (-23.97%) on September 30, 2024.
- Over the past year, COLL quarterly EBIT has dropped by -$15.58 million (-31.44%).
- COLL quarterly EBIT is now -48.52% below its all-time high of $65.99 million, reached on December 31, 2023.
Performance
COLL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$198.61 M
-$15.58 M-7.27%
September 30, 2024
Summary
- As of February 12, 2025, COLL TTM earnings before interest & taxes is $198.61 million, with the most recent change of -$15.58 million (-7.27%) on September 30, 2024.
- Over the past year, COLL TTM EBIT has increased by +$92.75 million (+87.61%).
- COLL TTM EBIT is now -7.27% below its all-time high of $214.19 million, reached on June 30, 2024.
Performance
COLL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
COLL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +362.9% | -31.4% | +87.6% |
| 3 y3 years | +181.7% | -31.4% | +87.6% |
| 5 y5 years | +937.3% | -31.4% | +87.6% |
COLL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +801.8% | -48.5% | +199.6% | -7.3% | +1152.9% |
| 5 y | 5-year | at high | +829.3% | -48.5% | +199.6% | -7.3% | +1010.5% |
| alltime | all time | at high | +269.1% | -48.5% | +199.6% | -7.3% | +295.5% |
Collegium Pharmaceutical EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $33.97 M(-24.0%) | $198.61 M(-7.3%) |
| Jun 2024 | - | $44.68 M(-17.2%) | $214.19 M(+2.4%) |
| Mar 2024 | - | $53.96 M(-18.2%) | $209.16 M(+31.5%) |
| Dec 2023 | $159.07 M(+362.9%) | $65.99 M(+33.2%) | $159.07 M(+50.3%) |
| Sep 2023 | - | $49.55 M(+24.9%) | $105.86 M(+37.9%) |
| Jun 2023 | - | $39.66 M(+924.8%) | $76.79 M(+59.2%) |
| Mar 2023 | - | $3.87 M(-69.7%) | $48.25 M(+40.4%) |
| Dec 2022 | $34.37 M(+94.8%) | $12.78 M(-37.6%) | $34.37 M(-374.1%) |
| Sep 2022 | - | $20.48 M(+84.2%) | -$12.54 M(-33.5%) |
| Jun 2022 | - | $11.12 M(-211.0%) | -$18.86 M(+39.0%) |
| Mar 2022 | - | -$10.01 M(-70.7%) | -$13.57 M(-176.9%) |
| Dec 2021 | $17.64 M(-68.8%) | -$34.12 M(-341.1%) | $17.64 M(-73.6%) |
| Sep 2021 | - | $14.15 M(-13.8%) | $66.76 M(-7.6%) |
| Jun 2021 | - | $16.41 M(-22.6%) | $72.23 M(-0.2%) |
| Mar 2021 | - | $21.20 M(+41.3%) | $72.39 M(+28.2%) |
| Dec 2020 | $56.46 M(-358.9%) | $15.00 M(-23.6%) | $56.46 M(+43.0%) |
| Sep 2020 | - | $19.63 M(+18.5%) | $39.48 M(+182.7%) |
| Jun 2020 | - | $16.56 M(+214.1%) | $13.96 M(-297.4%) |
| Mar 2020 | - | $5.27 M(-365.0%) | -$7.07 M(-67.6%) |
| Dec 2019 | -$21.81 M | -$1.99 M(-66.2%) | -$21.81 M(+161.8%) |
| Sep 2019 | - | -$5.88 M(+31.4%) | -$8.33 M(-36.3%) |
| Jun 2019 | - | -$4.48 M(-52.7%) | -$13.09 M(-15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$9.47 M(-182.4%) | -$15.51 M(-18.3%) |
| Dec 2018 | -$19.00 M(-74.6%) | $11.49 M(-208.0%) | -$19.00 M(-60.3%) |
| Sep 2018 | - | -$10.63 M(+54.1%) | -$47.89 M(-5.2%) |
| Jun 2018 | - | -$6.90 M(-46.7%) | -$50.52 M(-22.0%) |
| Mar 2018 | - | -$12.95 M(-25.6%) | -$64.74 M(-13.5%) |
| Dec 2017 | -$74.86 M(-20.4%) | -$17.40 M(+31.2%) | -$74.86 M(-12.0%) |
| Sep 2017 | - | -$13.26 M(-37.2%) | -$85.04 M(-13.4%) |
| Jun 2017 | - | -$21.12 M(-8.5%) | -$98.22 M(-3.3%) |
| Mar 2017 | - | -$23.08 M(-16.3%) | -$101.57 M(+8.0%) |
| Dec 2016 | -$94.08 M(+249.7%) | -$27.58 M(+4.3%) | -$94.08 M(+23.7%) |
| Sep 2016 | - | -$26.44 M(+8.0%) | -$76.03 M(+29.2%) |
| Jun 2016 | - | -$24.47 M(+57.0%) | -$58.85 M(+51.1%) |
| Mar 2016 | - | -$15.59 M(+63.6%) | -$38.95 M(+44.8%) |
| Dec 2015 | -$26.91 M(+52.3%) | -$9.53 M(+2.8%) | -$26.91 M(+29.9%) |
| Sep 2015 | - | -$9.27 M(+102.5%) | -$20.71 M(+15.4%) |
| Jun 2015 | - | -$4.58 M(+29.3%) | -$17.95 M(+2.8%) |
| Mar 2015 | - | -$3.54 M(+6.4%) | -$17.46 M(-1.2%) |
| Dec 2014 | -$17.66 M(+9.6%) | -$3.33 M(-48.9%) | -$17.66 M(+23.2%) |
| Sep 2014 | - | -$6.50 M(+59.1%) | -$14.34 M(+83.1%) |
| Jun 2014 | - | -$4.09 M(+9.2%) | -$7.83 M(+109.2%) |
| Mar 2014 | - | -$3.74 M | -$3.74 M |
| Dec 2013 | -$16.12 M | - | - |
FAQ
- What is Collegium Pharmaceutical annual earnings before interest & taxes?
- What is the all time high annual EBIT for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical annual EBIT year-on-year change?
- What is Collegium Pharmaceutical quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical quarterly EBIT year-on-year change?
- What is Collegium Pharmaceutical TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical TTM EBIT year-on-year change?
What is Collegium Pharmaceutical annual earnings before interest & taxes?
The current annual EBIT of COLL is $159.07 M
What is the all time high annual EBIT for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high annual earnings before interest & taxes is $159.07 M
What is Collegium Pharmaceutical annual EBIT year-on-year change?
Over the past year, COLL annual earnings before interest & taxes has changed by +$124.71 M (+362.88%)
What is Collegium Pharmaceutical quarterly earnings before interest & taxes?
The current quarterly EBIT of COLL is $33.97 M
What is the all time high quarterly EBIT for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high quarterly earnings before interest & taxes is $65.99 M
What is Collegium Pharmaceutical quarterly EBIT year-on-year change?
Over the past year, COLL quarterly earnings before interest & taxes has changed by -$15.58 M (-31.44%)
What is Collegium Pharmaceutical TTM earnings before interest & taxes?
The current TTM EBIT of COLL is $198.61 M
What is the all time high TTM EBIT for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high TTM earnings before interest & taxes is $214.19 M
What is Collegium Pharmaceutical TTM EBIT year-on-year change?
Over the past year, COLL TTM earnings before interest & taxes has changed by +$92.75 M (+87.61%)